STAT3-IN-13
CAS No. 2248552-86-3
STAT3-IN-13 ( —— )
产品货号. M35646 CAS No. 2248552-86-3
STAT3-IN-13 (compound 6f) 是一种有效的 STAT3 抑制剂。STAT3-IN-13 具有抗增殖作用,并以 0.46 μM 的KD 值与 STAT3 SH2 结构域结合。STAT3-IN-13 抑制 STAT3 Y705 的磷酸化和下游靶基因表达。STAT3-IN-13 在体外诱导细胞凋亡 (apoptosis),在体内抑制肿瘤的生长和转移。STAT3-IN-13 可用于癌症研究。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ¥1862 | 有现货 |
|
| 5MG | ¥3154 | 有现货 |
|
| 10MG | ¥4104 | 有现货 |
|
| 25MG | ¥6436 | 有现货 |
|
| 50MG | ¥8324 | 有现货 |
|
| 100MG | ¥10440 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称STAT3-IN-13
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述STAT3-IN-13 (compound 6f) 是一种有效的 STAT3 抑制剂。STAT3-IN-13 具有抗增殖作用,并以 0.46 μM 的KD 值与 STAT3 SH2 结构域结合。STAT3-IN-13 抑制 STAT3 Y705 的磷酸化和下游靶基因表达。STAT3-IN-13 在体外诱导细胞凋亡 (apoptosis),在体内抑制肿瘤的生长和转移。STAT3-IN-13 可用于癌症研究。
-
产品描述STAT3-IN-13 (compound 6f) is a potent STAT3 inhibitor. STAT3-IN-13 has anti-proliferative effects and binds to the STAT3 SH2 domain with a KD of 0.46 μM. STAT3-IN-13 inhibits the phosphorylation of STAT3 Y705 and downstream target gene expression. STAT3-IN-13 induces apoptosis in vitro and suppresses the growth and metastasis of tumor in vivo. STAT3-IN-13 can be used for cancer research.
-
体外实验STAT3-IN-13 (compound 6f) (48 hours) has anti-proliferative activity with IC50 values of 0.25, 0.11 and 0.55 μM for 143B, HOS and MG63 cells, respectively.STAT3-IN-13 (compound 6f) (0.001-100 μM) binds to STAT3 and interacts with STAT3586?685 in a concentration dependent manner with a KD of 0.96 μM.STAT3-IN-13 (compound 6f) (0-1.0 μM; 24 hours; 143B and HOS cells) inhibits STAT3 Y705 phosphorylation and suppresses STAT3 in tumor cells.STAT3-IN-13 (compound 6f) (0-1.0 μM; 48 hours; 143B cells) induces apoptosis in a dose-dependent manner.Apoptosis Analysis Cell Line:143B cells Concentration:0, 0.2, 0.5, and 1 μM Incubation Time:48 hours Result:Increased the percentage of apoptosis rates of 3.4%, 8.7%, 10.7%, and 23.3% at 0, 0.2, 0.5 and 1 μM, respectively. Western Blot Analysis Cell Line:143B and HOS cells Concentration:0, 0.2, 0.5 and 1.0 μM Incubation Time:24 hours Result:Inhibited STAT3 Y705 phosphorylation and downstream target gene expression including Bcl-2 and VEGF, retained good antitumor activities against control tumor cells without STAT3 knockdown.
-
体内实验STAT3-IN-13 (compound 6f) (10-20 mg/kg; i.p.; twice daily, for 4 weeks; nude mice) blocks osteosarcoma growth and metastasis in vivo.Animal Model:Nude mice Dosage:10 and 20 mg/kg Administration:Intraperitoneal injection; twice daily, for 4 weeks Result:Suppressed tumor weight at a dose of 10 mg/kg.
-
同义词——
-
通路JAK/STAT Signaling
-
靶点STAT
-
受体STAT
-
研究领域——
-
适应症——
化学信息
-
CAS Number2248552-86-3
-
分子量436.49
-
分子式C21H20N6O3S
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO 中的溶解度 : 125 mg/mL (286.38 mM; 超声助溶 )
-
SMILESC(#N)C=1C2=C(SC1NC(=O)C=3C=NN(C)C3)CN(C(NC4=CC=C(OC)C=C4)=O)CC2
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Jin W, et, al. Discovery of 2-Amino-3-cyanothiophene Derivatives as Potent STAT3 Inhibitors for the Treatment of Osteosarcoma Growth and Metastasis. J Med Chem. 2022 May 12;65(9):6710-6728. ?
021-51111890
购物车()
sales@molnova.cn

